Patienthèque of Finisterian (South of Brittany) Children With Cystic Fibrosis in the Time of Precision Medicine

Sponsor
University Hospital, Brest
Study ID
NCT04137133
Status
Recruiting
Apply to this trial

Conditions

  • Cystic Fibrosis

Eligibility Criteria

Sex
ALL
Age
N/A - 18 Years
Healthy Volunteers
Not accepted

Interventions

  • collection — DIAGNOSTIC_TEST
    bronchial secretions, blood, stools, superficial skin sample, dental plaque sample and urine

Study Details

The objective of this study is to evaluate the relevance of Porphyromonas as a biomarker predicting the risk of P. aeruginosa primocolonization in children form 0 to 18 years old with cystic fibrosis.

Key Dates

First listed
Oct 23, 2019
Start date
Mar 21, 2022
Status verified
Apr 2024
Primary completion
Mar 31, 2030
Completion
Mar 31, 2030

Study Design

Enrollment
20 participants (estimated)
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC

Arms

  • Experimental: collection of expectoration, stools and blood

Primary Outcome Measure

Presence of P. aeruginosa in bacterial sputum cultures in one of bronchial secretions sample [ Time Frame: 3 years ]

Central Contacts

Related Studies